Evidence map›Paper›PMID 34500647›Full record

ArticleMolecules (Basel, Switzerland)2021

Trifluoromethylated Flavonoid-Based Isoxazoles as Antidiabetic and Anti-Obesity Agents: Synthesis, In Vitro

Faisal K Algethami, Ilyes Saidi, Hani Nasser Abdelhamid, Mohamed R Elamin, Babiker Y Abdulkhair, Amani Chrouda, Hichem Ben Jannet

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. 3-(((1Molecules (Basel, Switzerland) · 2022
    Article
  11. Identification of Cyclic Sulfonamides with anPharmaceuticals (Basel, Switzerland) · 2022
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Faisal K AlgethamiDepartment of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11432, Saudi Arabia.ORCID 0000-0003-4280-1538
Ilyes SaidiLaboratory of Heterocyclic Chemistry, Natural Products and Reactivity (LR11ES39), Medicinal Chemistry and Natural Products Team, Faculty of Science of Monastir, University of Monastir, Avenue of Environment, Monastir 5019, Tunisia.ORCID 0000-0002-6408-1482
Hani Nasser AbdelhamidDepartment of Chemistry, Advanced Multifunctional Materials Laboratory, Faculty of Science, Assiut University, Assiut 71575, Egypt.
Mohamed R ElaminDepartment of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11432, Saudi Arabia.
Babiker Y AbdulkhairDepartment of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11432, Saudi Arabia.
Amani ChroudaDepartment of Chemistry, College of Science Al-Zulfi, Majmaah University, Al-Majmaah 11952, Saudi Arabia.ORCID 0000-0003-0939-9890
Hichem Ben JannetLaboratory of Heterocyclic Chemistry, Natural Products and Reactivity (LR11ES39), Medicinal Chemistry and Natural Products Team, Faculty of Science of Monastir, University of Monastir, Avenue of Environment, Monastir 5019, Tunisia.ORCID 0000-0001-5858-1803
Imam Mohammad ibn Saud Islamic University · SAUniversity of Monastir · TNAssiut University · EGMajmaah University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus is a major health problem globally. The management of carbohydrate digestion provides an alternative treatment. Flavonoids constitute the largest group of polyphenolic compounds, produced by plants widely consumed as food and/or used for therapeutic purposes. As such, isoxazoles have attracted the attention of medicinal chemists by dint of their considerable bioactivity. Thus, the main goal of this work was to discover new hybrid molecules with properties of both flavonoids and isoxazoles in order to control carbohydrate digestion. Moreover, the trifluoromethyl group is a key entity in drug development, due to its strong lipophilicity and metabolic stability. Therefore, the present work describes the condensation of a previously synthesized trifluoromethylated flavonol with different aryl nitrile oxides, affording 13 hybrid molecules indicated as trifluoromethylated flavonoid-based isoxazoles. The structures of the obtained compounds were deduced from by

Indexed as

alpha-Amylasesalpha-GlucosidasesAnti-Obesity AgentsDiabetes MellitusFlavonoidsGlycoside Hydrolase InhibitorsHumansHypoglycemic AgentsIsoxazolesMolecular Docking SimulationStructure-Activity Relationshipalpha-Amylasesalpha-GlucosidasesAnti-Obesity AgentsFlavonoidsGlycoside Hydrolase InhibitorsHypoglycemic AgentsIsoxazolesantidiabeticanti-obesitycycloadditionflavonoidsmolecular dockingSAR analysistrifluoromethylated flavonoid-based isoxazolesα-amylase inhibition

Identifiers

PMID34500647
PMCPMC8434401
OpenAlexW3196765255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.